E
ENCell Co Ltd
KOSDAQ:456070
ENCell Co Ltd
KOSDAQ:456070
Price:
16 700
KRW
-4.02%
Market Cap:
₩183B
Relative Value
The Relative Value of one ENCell Co Ltd stock under the Base Case scenario is 6 392.64 KRW. Compared to the current market price of 16 700 KRW, ENCell Co Ltd is Overvalued by 62%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
6 392.64
KRW
Overvaluation 62%
E
Multiples Across Competitors
Competitors Multiples
ENCell Co Ltd Competitors
ENCell Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
E
|
ENCell Co Ltd
KOSDAQ:456070
|
182.1B KRW | 30.8 | -10.2 | -12 | -8.9 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1.1T USD | 370.5 | 4 387.5 | 1 391.1 | 2 972.2 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
188.8B USD | 4.2 | 28.2 | 19.7 | 26.5 | |
| US |
|
Danaher Corp
NYSE:DHR
|
145.3B USD | 5.9 | 40.2 | 22.3 | 33.9 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
79.2T KRW | 8.4 | 29 | 29.1 | 38.8 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
36.5B CHF | 5.6 | 38.8 | 28.4 | 28.4 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
291.5B CNY | 6.6 | 19.4 | 19.7 | 19.7 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
35.1B USD | 5 | 26.9 | 19.7 | 23.3 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
27.9B USD | 1.7 | 20.5 | 11.5 | 17.3 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
27.6B USD | 6.9 | 31.8 | 23.4 | 26 | |
| CN |
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
164.8B HKD | 7.3 | 34.8 | 24.4 | 24.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
